Launch of weight-loss drug in UK helps Danish firm to market value of $428bn
The success of the weightloss drug Wegovy has helped its Danish manufacturer to overtake the French luxury group LVMH as Europe’s most valuable company.
After Novo Nordisk, which specialises in diabetes and weight loss treatments, launched Wegovy in the UK on Monday, its share price rose 0.7% to Danish kronor 1,310.80 ($190).
